Anja is Head Regulatory Affairs and Deputy CEO at SFL.
She provides strategic regulatory support to SFL’s clients for the development, filing and maintenance of healthcare products, with proven ability to develop and implement regulatory strategies for a broad range of product types, including small molecules, biologics, cell and gene therapies.
By leading international regulatory projects and regularly interacting with Regulatory Authorities, clients and cross-functional teams, she has significant experience in senior level negotiations and supervises a team of high performing regulatory affairs professionals.
She has extensive knowledge of regulatory procedures and hands-on experience in overseeing preparation of high quality regulatory documentation, such as CTAs, MAAs and lifecycle management.
Anja holds a MSc degree in Biology from Albert-Ludwigs-University Freiburg, Germany. During her studies, she focused on Biochemistry, Cell Biology, Immunology and Pharmacology.